Jiangsu Chinagreen Biological Technology Group Co., Ltd. (SHE:300970)

SHE:300970 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	373.32	361.14	409.95	431.65	411.21	192
Trading Asset Securities	-	-	-	100.17	359.24	39.06
Cash & Short-Term Investments	373.32	361.14	409.95	531.82	770.45	231.06
Cash Growth	10.81%	-11.91%	-22.92%	-30.97%	233.44%	3.58%
Accounts Receivable	20	16.7	18.69	12.46	36.95	15.53
Other Receivables	2.12	1.89	3.52	2.08	1.6	0.16
Receivables	22.12	18.59	22.21	14.54	38.55	15.69
Inventory	202.63	196.07	188.2	157.08	107.92	83.82
Prepaid Expenses	-	1.06	1.05	1.05	0.93	4.57
Other Current Assets	4.09	3.12	6.44	5.15	1.96	0.87
Total Current Assets	602.16	579.98	627.85	709.64	919.81	336.02
Property, Plant & Equipment	1,624	1,642	1,410	1,180	864.92	751.58
Long-Term Investments	0.32	0.33	0.5	0.44	-	-
Other Intangible Assets	57.55	58.02	58.55	51.38	52.4	53.31
Long-Term Deferred Charges	0.02	0.04	0.27	0.53	0.6	0.04
Other Long-Term Assets	23.11	24.73	21.82	38.42	38.79	23.78
Total Assets	2,307	2,306	2,119	1,980	1,877	1,165
Accounts Payable	73.36	73.31	78.53	56.84	38.82	29.17
Accrued Expenses	27.66	28.59	28.25	23.12	14.47	19.23
Short-Term Debt	-	-	-	14.01	50.06	40.03
Current Portion of Long-Term Debt	48.75	47.63	62.7	46.56	42.77	15.8
Current Portion of Leases	-	1.22	1.13	1.2	1.2	-
Current Income Taxes Payable	0.22	0.03	-	0.69	0.34	0
Current Unearned Revenue	2.44	3.43	3.64	8.4	2.16	2.91
Other Current Liabilities	57.73	68.38	59.53	34.16	22.06	29.52
Total Current Liabilities	210.17	222.59	233.77	184.97	171.88	136.67
Long-Term Debt	313.09	302.94	170.41	226.93	210.06	133
Long-Term Leases	216.04	214.41	99.1	0.91	3.38	-
Long-Term Unearned Revenue	43.61	45.85	47.75	45.01	53.6	44
Other Long-Term Liabilities	0.27	0.33	-	-	-	-
Total Liabilities	783.18	786.12	551.03	457.83	438.92	313.67
Common Stock	120.2	120.2	117.89	116.7	116.7	43.76
Additional Paid-In Capital	918.55	915.76	873.01	843.93	840.75	317.75
Retained Earnings	487.62	486.08	556.75	549.74	471.49	486.33
Treasury Stock	-30.01	-30.01	-	-	-	-
Total Common Equity	1,496	1,492	1,548	1,510	1,429	847.84
Minority Interest	27.79	27.37	20.29	12.17	8.65	3.21
Shareholders' Equity	1,524	1,519	1,568	1,523	1,438	851.05
Total Liabilities & Equity	2,307	2,306	2,119	1,980	1,877	1,165
Total Debt	577.88	566.2	333.34	289.61	307.48	188.84
Net Cash (Debt)	-204.56	-205.06	76.62	242.21	462.97	42.22
Net Cash Growth	-	-	-68.37%	-47.68%	996.49%	-26.64%
Net Cash Per Share	-1.54	-1.77	0.66	2.07	4.18	0.41
Filing Date Shares Outstanding	117.86	117.86	115.54	116.7	116.7	116.7
Total Common Shares Outstanding	117.86	117.86	115.54	116.7	116.7	87.52
Working Capital	392	357.39	394.08	524.67	747.93	199.35
Book Value Per Share	12.70	12.66	13.39	12.94	12.24	9.69
Tangible Book Value	1,439	1,434	1,489	1,459	1,377	794.53
Tangible Book Value Per Share	12.21	12.17	12.89	12.50	11.80	9.08
Buildings	-	793.97	735.55	548.81	475.13	397.44
Machinery	-	1,286	1,071	816.14	702.18	582.41
Construction In Progress	-	95.3	93.56	291.66	83.74	92.41

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.